Related Experiment Video
Updated: Jun 4, 2026
08:36
The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
Assessing risk of bias in randomized controlled trials
Marianna Purgato1, Corrado Barbui, Andrea Cipriani
1Department of Public Health and Community Medicine, Section of Psychiatry and Clinical Psychology, University of Verona, Italy.
Epidemiologia E Psichiatria Sociale
|February 17, 2011
Summary
Randomized controlled trials (RCTs) are crucial for healthcare research but can be affected by bias. This paper examines how to assess RCT quality by evaluating comprehensive reporting and the trial
Area of Science:
- Clinical Trials Methodology
- Health Services Research
- Evidence-Based Practice
Background:
- Randomized controlled trials (RCTs) are the gold standard for evaluating healthcare interventions.
- However, RCTs are susceptible to various biases that can compromise research integrity and findings.
- Ensuring the quality of RCTs is paramount for reliable healthcare decision-making.
Purpose of the Study:
- To discuss methods for appraising the quality of randomized controlled trials.
- To explore how comprehensive reporting impacts trial validity.
- To investigate the association between trial characteristics and the risk of bias.
Main Methods:
- The paper reviews established criteria for assessing the completeness and accuracy of trial reporting against study protocols.
- It examines methodologies for identifying and evaluating biases inherent in trial design and execution.
- The discussion includes how to link specific trial characteristics to potential risks of bias.
Main Results:
- Trial quality assessment requires evaluating both the fidelity of reporting and the intrinsic risk of bias.
- Incomplete or inconsistent reporting can significantly undermine the validity of RCT results.
- Certain trial characteristics are demonstrably associated with an increased risk of bias, affecting outcome interpretation.
Conclusions:
- A robust appraisal of RCT quality necessitates a dual focus on reporting completeness and bias assessment.
- Methodological rigor in trial design and transparent reporting are essential for minimizing bias.
- Understanding the link between trial characteristics and bias risk enhances the reliability of evidence-based healthcare interventions.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:13Randomized Experiments
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
01:29Bias in Epidemiological Studies
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:25Strategies for Assessing and Addressing Confounding
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...